Maine cannabis office issues patient advisory for medical flower

Maine's OCP flags issue affecting medical cannabis flower, amid ongoing state quality and testing concerns.

FILE — testing lab · NIST / public domain

Maine's Office of Cannabis Policy issued a patient advisory on medical cannabis flower on May 1, according to Maine.gov. The specific nature of the advisory was not detailed in the source material, but the timing aligns with broader quality and labeling concerns that have surfaced in Maine's cannabis market over recent months.

The advisory appears in a regulatory environment marked by recurring product-safety questions. In April, a dispensary owner told WGME the state was not requiring labels for mold-affected products. Meanwhile, lawmakers have considered a medical cannabis testing bill as of February. Maine's adult-use market currently operates with 193 retail locations, 80 cultivation licenses, and 86 manufacturing licenses in place.

Watch whether the OCP clarifies the advisory's scope and whether it triggers formal product recalls or enforcement action. The advisory's details will signal whether Maine is tightening labeling or testing requirements in response to identified quality gaps.